Earlier, less intrusive and less costly tests for Alzheimer’s disease would allow doctors to try intervention therapies earlier in the disorder’s development, in hopes of slowing or curbing progression of the disease.
Taubman Scholar Henry Paulson, MD, PhD, was interviewed recently about some new blood tests making the news among dementia researchers. Read what he has to say.
